The LCTC has selected over 25 academic institutions,
or Centers, to receive infrastructure support grants to facilitate their
clinical trial research activities and to help each of them maintain
readiness for participation in testing for new lupus therapies in clinical
trials. Selection criteria for the Centers include having a strong record
in running clinical trials, a range of scientific expertise, and
geographic as well as patient diversity.
The LCTC engages in many
different types of educational activities aimed at demonstrating the need
for lupus clinical research and highlighting issues that are unique to
lupus clinical research. For example, the LCTC communicates with potential
clinical trial sponsors about the goals of the LCTC, hosts informational
booths at major lupus organization conferences, and sponsors meetings of
national lupus educational organizations.
Unifying Force in the Lupus Community
strives to be a unifying force in the lupus community. For example, the
LCTC encourages lupus clinical researchers from the Centers to come
together at meetings planned by the LCTC to share their expertise and
experiences, with the goal of advancing the science of high quality,
efficient lupus clinical trials.
The LCTC is not a clinical trial sponsor, contract research
organization, site management organization, or similar entity. The LCTC
does not participate in the conduct of clinical
Arnold M. Snider
Stephen A. Paget,
Cornell School of Medicine
Joseph E. Craft, M.D.
Bevra H. Hahn, M.D.
UCLA School of
Matthew H. Liang, M.D., M.P.H.
Harvard School of
Michael D. Lockshin, M.D.
Cornell School of
UCSF School of Medicine
Chair of the Scientific
David S. Pisetsky, M.D., Ph.D.